VKTX - Wall Street Estimates - Viking Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 32.65

0.276 %

$ 3.64 B

Market Cap

-34.73

P/E

Price Target Average

229.39%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

27.79%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Viking Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for VKTX of $108 , with forecasts ranging from a low of $74 to a high of $138 .

VKTX Lowest Price Target Wall Street Target

74 USD 126.65%

VKTX Average Price Target Wall Street Target

108 USD 229.39%

VKTX Highest Price Target Wall Street Target

138 USD 322.66%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free